Welcome to LookChem.com Sign In|Join Free

CAS

  • or
6-Bromonaphthalene-2-carbaldehyde is an aromatic bromoaldehyde belonging to the naphthalene family, characterized by the integration of bromine, naphthalene, and aldehyde functional groups. The presence of the bromo group enhances its reactivity, making it a versatile compound for various organic synthesis processes. It is primarily used as a reagent in organic chemistry and may also have potential applications in the production of pharmaceutical intermediates, agrochemicals, and dyes. However, due to its brominated nature, it requires careful handling to mitigate potential health hazards and environmental pollution.

170737-46-9

Post Buying Request

170737-46-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

170737-46-9 Usage

Uses

Used in Organic Synthesis:
6-Bromonaphthalene-2-carbaldehyde is used as a reagent in organic synthesis for its reactivity and versatility in forming various chemical compounds. The presence of the bromo group allows for easy substitution reactions, making it a valuable component in the synthesis of complex organic molecules.
Used in Pharmaceutical Industry:
6-Bromonaphthalene-2-carbaldehyde is used as a pharmaceutical intermediate for the development of new drugs. Its unique structure and reactivity enable the creation of novel drug candidates with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, 6-bromonaphthalene-2-carbaldehyde is used as a precursor in the synthesis of various agrochemicals, such as pesticides and herbicides. Its reactivity and functional groups contribute to the development of effective and targeted agrochemical products.
Used in Dye Industry:
6-Bromonaphthalene-2-carbaldehyde is used as a starting material in the production of dyes due to its aromatic structure and potential for color development. Its reactivity allows for the synthesis of a wide range of dyes with different properties and applications.
Used in Environmental and Health Safety:
6-Bromonaphthalene-2-carbaldehyde is used in research and development efforts to understand and mitigate its potential health hazards and environmental pollution. This includes the development of safer handling procedures, waste disposal methods, and the creation of alternative compounds with reduced environmental impact.

Check Digit Verification of cas no

The CAS Registry Mumber 170737-46-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,0,7,3 and 7 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 170737-46:
(8*1)+(7*7)+(6*0)+(5*7)+(4*3)+(3*7)+(2*4)+(1*6)=139
139 % 10 = 9
So 170737-46-9 is a valid CAS Registry Number.
InChI:InChI=1/C11H7BrO/c12-11-4-3-9-5-8(7-13)1-2-10(9)6-11/h1-7H

170737-46-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-Bromo-2-naphthaldehyde

1.2 Other means of identification

Product number -
Other names 6-bromonaphthalene-2-carbaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:170737-46-9 SDS

170737-46-9Synthetic route

(6-bromo-2-naphthy)methanol
100751-63-1

(6-bromo-2-naphthy)methanol

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

Conditions
ConditionsYield
With Dess-Martin periodane In dichloromethane at 20℃; for 1h;100%
With pyridinium chlorochromate In dichloromethane for 1h; Reflux;98%
With pyridinium chlorochromate In dichloromethane for 5h; Reflux;95%
methyl 6-bromo-2-naphthoate
33626-98-1

methyl 6-bromo-2-naphthoate

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

Conditions
ConditionsYield
Stage #1: methyl 6-bromo-2-naphthoate With diisobutylaluminium hydride In tetrahydrofuran at 0 - 20℃; Inert atmosphere;
Stage #2: With pyridinium chlorochromate In dichloromethane at 60℃; for 6h; Inert atmosphere;
95%
Stage #1: methyl 6-bromo-2-naphthoate With diisobutylaluminium hydride In tetrahydrofuran at 0 - 20℃; for 12h;
Stage #2: With pyridinium chlorochromate In dichloromethane for 5h; Reflux;
95%
With manganese dioxide; dibal In methanol; dichloromethane; toluene61%
2,6-dibromonaphthalene
13720-06-4

2,6-dibromonaphthalene

N,N-dimethyl-formamide
68-12-2, 33513-42-7

N,N-dimethyl-formamide

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

Conditions
ConditionsYield
With n-butyllithium In tetrahydrofuran at -78℃; for 0.5h; Inert atmosphere;78%
methyl 6-bromo-2-naphthoate
33626-98-1

methyl 6-bromo-2-naphthoate

A

(6-bromo-2-naphthy)methanol
100751-63-1

(6-bromo-2-naphthy)methanol

B

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

Conditions
ConditionsYield
With diisobutylaluminium hydride In toluene at -78℃; Inert atmosphere;A 35%
B 57%
2-Bromo-6-methoxynaphthalene
5111-65-9

2-Bromo-6-methoxynaphthalene

A

6-methoxynaphthalene-2-carbaldehyde
3453-33-6

6-methoxynaphthalene-2-carbaldehyde

B

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

Conditions
ConditionsYield
With n-butyllithium; sodium chloride In tetrahydrofuran; hexanes on silica gel; hexane; ethyl acetate; N,N-dimethyl-formamideA n/a
B 2.86 g (91%)
6-bromo-2-naphthoic acid
5773-80-8

6-bromo-2-naphthoic acid

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: borane-THF / tetrahydrofuran / 0 - 25 °C
2: pyridinium chlorochromate / dichloromethane / 25 °C
View Scheme
Multi-step reaction with 3 steps
1: sulfuric acid / 7 h / Reflux
2: lithium aluminium tetrahydride / tetrahydrofuran / 2 h / -10 - 0 °C / Inert atmosphere
3: Dess-Martin periodane / dichloromethane / 2 h / 0 °C / Inert atmosphere
View Scheme
Multi-step reaction with 2 steps
1: borane-THF / tetrahydrofuran / 0 - 20 °C
2: Dess-Martin periodane / dichloromethane / 0 - 20 °C
View Scheme
C9H15NO5
1017593-93-9

C9H15NO5

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

C20H20BrNO5
1017594-45-4

C20H20BrNO5

Conditions
ConditionsYield
Stage #1: C9H15NO5 With ytterbium(III) triflate In dichloromethane at 20℃; for 0.5h;
Stage #2: 6-bromo-naphthalene-2-carboxaldehyde In dichloromethane at 20℃; Further stages.;
100%
6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

trimethyleneglycol
504-63-2

trimethyleneglycol

6-bromo-2-(1,3-dioxan-2-yl)naphthalene
1129491-95-7

6-bromo-2-(1,3-dioxan-2-yl)naphthalene

Conditions
ConditionsYield
With zirconium(IV) chloride; orthoformic acid triethyl ester In dichloromethane at 20℃; for 2h; Inert atmosphere;96%
6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

(6-bromo-2-naphthy)methanol
100751-63-1

(6-bromo-2-naphthy)methanol

Conditions
ConditionsYield
With methanol; sodium tetrahydroborate at 0 - 20℃; for 4h; Inert atmosphere;96%
2-(Z-3-chloroprop-2-enyl)-4,4,5,5-tetramethyl-1,2,3-dioxaborolane
158813-39-9

2-(Z-3-chloroprop-2-enyl)-4,4,5,5-tetramethyl-1,2,3-dioxaborolane

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

(R,Z)-1-(6-bromonaphthalen-2-yl)-4-chlorobut-3-en-1-ol

(R,Z)-1-(6-bromonaphthalen-2-yl)-4-chlorobut-3-en-1-ol

Conditions
ConditionsYield
With methanol; (2S)-2-((2-hydroxy-3-(triphenylsilyl)benzyl)amino)-2-(3-hydroxyadamantan-1-yl) 1-(isoindolin-2-yl)ethan-1-one; zinc dimethoxide In toluene at 22℃; for 14h; Glovebox; Inert atmosphere; Sealed tube; stereoselective reaction;95%
(Z)-4,4,5,5-tetramethyl-2-(4,4,4-trifluorobut-2-en-1-yl)-1,3,2-dioxaborolane

(Z)-4,4,5,5-tetramethyl-2-(4,4,4-trifluorobut-2-en-1-yl)-1,3,2-dioxaborolane

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

(R,Z)-1-(6-bromonaphthalen-2-yl)-5,5,5-trifluoropent-3-en-1-ol

(R,Z)-1-(6-bromonaphthalen-2-yl)-5,5,5-trifluoropent-3-en-1-ol

Conditions
ConditionsYield
With methanol; C33H38N2O2Si; zinc dimethoxide In toluene at 4℃; for 2h; Glovebox; Inert atmosphere; Sealed tube; stereoselective reaction;93%
ethylene glycol
107-21-1

ethylene glycol

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

2-(6-bromonaphthalen-2-yl)-1,3-dioxolane
935473-01-1

2-(6-bromonaphthalen-2-yl)-1,3-dioxolane

Conditions
ConditionsYield
With toluene-4-sulfonic acid In toluene for 48h; Heating;92%
With toluene-4-sulfonic acid for 48h; Heating;92%
With toluene-4-sulfonic acid In toluene at 120℃; for 48h;52%
With toluene-4-sulfonic acid In toluene for 48h; Reflux; Dean-Stark;48%
diethyl (4-bromobenzyl)phosphonate
38186-51-5

diethyl (4-bromobenzyl)phosphonate

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

(E)-2-bromo-6-(4-bromostyryl)naphthalene

(E)-2-bromo-6-(4-bromostyryl)naphthalene

Conditions
ConditionsYield
With potassium tert-butylate In dimethyl sulfoxide at 0 - 20℃; for 12h;91%
C9H15NO5
1017593-93-9

C9H15NO5

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

C20H20BrNO5
1017594-71-6

C20H20BrNO5

Conditions
ConditionsYield
With magnesium sulfate In methanol; dichloromethane91%
diisopropyl trimethylsily phosphite
24350-54-7

diisopropyl trimethylsily phosphite

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

(R)-diisopropyl ((6-bromonaphthalen-2-yl)(hydroxy)methyl)phosphonate

(R)-diisopropyl ((6-bromonaphthalen-2-yl)(hydroxy)methyl)phosphonate

Conditions
ConditionsYield
With 3,3’-bis[3,5-bis(perfluoropropan-2-yl)phenyl]-1,1’-binaphthalene-2,2’-sulfonimide In diethyl ether at -50℃; for 96h; Abramov Phosphorylation; enantioselective reaction;88%
malonic acid
141-82-2

malonic acid

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

(E)-3-(6-bromonaphthalen-2-yl)acrylic acid

(E)-3-(6-bromonaphthalen-2-yl)acrylic acid

Conditions
ConditionsYield
With piperidine; pyridine at 90℃; for 8h; Knoevenagel Condensation;88%
2-methallyltrimethylsilane
18292-38-1

2-methallyltrimethylsilane

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

(1R)-1-(6-bromonaphth-2-yl)-3-methyl-3-buten-1-ol
1448863-14-6

(1R)-1-(6-bromonaphth-2-yl)-3-methyl-3-buten-1-ol

Conditions
ConditionsYield
Stage #1: 2-methallyltrimethylsilane; 6-bromo-naphthalene-2-carboxaldehyde With 1-methoxy-2-methyl-1-trimethylsiloxy-1-propene; (R)-3,3'-bis[4-methyl-3,5-dinitrophenyl]-1,1'-binaphthyl-2,2'-disulfonimide In toluene at -78℃; for 72h; Hosomi-Sakurai Reaction; Inert atmosphere;
Stage #2: With hydrogenchloride In water; toluene at -78 - 20℃; enantioselective reaction;
82%
6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

trimethylsilylacetylene
1066-54-2

trimethylsilylacetylene

6-[(trimethylsilyl)ethynyl]-2-naphthaldehyde

6-[(trimethylsilyl)ethynyl]-2-naphthaldehyde

Conditions
ConditionsYield
With bis-triphenylphosphine-palladium(II) chloride; copper(l) iodide In tetrahydrofuran at 20℃;82%
aniline
62-53-3

aniline

9,10-phenanthrenequinone
84-11-7

9,10-phenanthrenequinone

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

2-(6-bromonaphthalen-2-yl)-1-phenyl-1H-phenanthro[9,10-d]imidazole

2-(6-bromonaphthalen-2-yl)-1-phenyl-1H-phenanthro[9,10-d]imidazole

Conditions
ConditionsYield
With ammonium acetate; acetic acid for 24h; Reflux; Inert atmosphere;82%
With ammonium acetate; acetic acid at 130℃; for 18h; Inert atmosphere;70%
3-(1-adamantyl)-4,5-methylenedioxy-1-phenyl boronic acid
459423-02-0

3-(1-adamantyl)-4,5-methylenedioxy-1-phenyl boronic acid

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

6-[3-(1-adamantyl)-4,5-methylenedioxyphenyl]-2-naphthaldehyde

6-[3-(1-adamantyl)-4,5-methylenedioxyphenyl]-2-naphthaldehyde

Conditions
ConditionsYield
With potassium carbonate; tetrakis(triphenylphosphine)palladium (0) In 1,2-dimethoxyethane; water81%
9-fluorenylmethyl carbamate
84418-43-9

9-fluorenylmethyl carbamate

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

allyl-trimethyl-silane
762-72-1

allyl-trimethyl-silane

(R)-(9H-fluoren-9-yl)methyl (1-(6-bromonaphthalen-2-yl)but-3-en-1-yl)carbamate

(R)-(9H-fluoren-9-yl)methyl (1-(6-bromonaphthalen-2-yl)but-3-en-1-yl)carbamate

Conditions
ConditionsYield
With (R)-3,3'-bis(4-nitrophenyl)-1,1'-binaphthyl-2,2'-disulfonimide In chloroform at 15℃; for 288h; enantioselective reaction;80%
morpholine
110-91-8

morpholine

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

6-morpholin-4-yl-naphthalene-2-carbaldehyde
1114962-61-6

6-morpholin-4-yl-naphthalene-2-carbaldehyde

Conditions
ConditionsYield
With tri-tert-butyl phosphine; palladium diacetate; caesium carbonate In toluene for 72h; Reflux; Inert atmosphere;79%
1-methyl-piperazine
109-01-3

1-methyl-piperazine

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

6-(4-methylpiperazin-1-yl)naphthalene-2-carbaldehyde
1290035-73-2

6-(4-methylpiperazin-1-yl)naphthalene-2-carbaldehyde

Conditions
ConditionsYield
With tri-tert-butyl phosphine; palladium diacetate; caesium carbonate In toluene for 72h; Reflux; Inert atmosphere;77%
2-Methyl-1,2-propanediol
558-43-0

2-Methyl-1,2-propanediol

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

(S)-2-(6-bromonaphthalen-2-yl)-4,4-dimethyl-1,3-dioxolane

(S)-2-(6-bromonaphthalen-2-yl)-4,4-dimethyl-1,3-dioxolane

Conditions
ConditionsYield
With C80H73NO6P2 In toluene at 20℃; for 52h; Molecular sieve; enantioselective reaction;77%
1-propylmagnesium chloride
2234-82-4

1-propylmagnesium chloride

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

1-(6-bromonaphthalen-2-yl)butan-1-ol

1-(6-bromonaphthalen-2-yl)butan-1-ol

Conditions
ConditionsYield
In tetrahydrofuran; diethyl ether at 0 - 20℃; for 1h;76%
piperidine
110-89-4

piperidine

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

6-(piperidin-1-yl)naphthalene-2-carbaldehyde
1208971-02-1

6-(piperidin-1-yl)naphthalene-2-carbaldehyde

Conditions
ConditionsYield
With palladium diacetate; caesium carbonate; 2,2'-bis-(diphenylphosphino)-1,1'-binaphthyl In toluene for 12h; Reflux;75%
With caesium carbonate; tri-tert-butyl phosphine; palladium diacetate In toluene for 72h; Reflux;70%
With tri-tert-butyl phosphine; palladium diacetate; caesium carbonate In toluene for 72h; Reflux; Inert atmosphere;70%
N-(2-aminomethyl)-5-isoquinolinesulfonamide
84468-17-7

N-(2-aminomethyl)-5-isoquinolinesulfonamide

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

N-(2-(((6-bromonaphthalen-2-yl)methyl)amino)ethyl)isoquinoline-5-sulfonamide

N-(2-(((6-bromonaphthalen-2-yl)methyl)amino)ethyl)isoquinoline-5-sulfonamide

Conditions
ConditionsYield
With sodium tris(acetoxy)borohydride; acetic acid In tetrahydrofuran at 20℃; for 19h;74%
2′,4′-diethoxyacetophenone
22924-18-1

2′,4′-diethoxyacetophenone

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

C35H34BrNO4

C35H34BrNO4

Conditions
ConditionsYield
With ammonium acetate; acetic acid at 120℃; for 6h;73.6%
ethyltriphenylphosphonium bromide
1530-32-1

ethyltriphenylphosphonium bromide

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

C13H11Br

C13H11Br

Conditions
ConditionsYield
Stage #1: ethyltriphenylphosphonium bromide With potassium tert-butylate In tetrahydrofuran at -40 - -30℃; for 2h; Inert atmosphere;
Stage #2: 6-bromo-naphthalene-2-carboxaldehyde In tetrahydrofuran at -40 - -30℃; for 0.5h; Inert atmosphere;
71%
Methyltriphenylphosphonium bromide
1779-49-3

Methyltriphenylphosphonium bromide

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

C12H9Br
170737-47-0

C12H9Br

Conditions
ConditionsYield
Stage #1: Methyltriphenylphosphonium bromide With potassium tert-butylate In tetrahydrofuran at 20℃; for 0.25h; Wittig Olefination; Inert atmosphere;
Stage #2: 6-bromo-naphthalene-2-carboxaldehyde In tetrahydrofuran at -20 - 20℃; Inert atmosphere;
71%
6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

6-(piperidin-1-yl)naphthalene-2-carbaldehyde
1208971-02-1

6-(piperidin-1-yl)naphthalene-2-carbaldehyde

Conditions
ConditionsYield
With piperidine; tri-tert-butyl phosphine; palladium diacetate; caesium carbonate In toluene for 72h; Buchwald-Hartwig Coupling; Reflux;70%
Multi-step reaction with 3 steps
1: toluene-4-sulfonic acid / toluene / 48 h / Reflux; Dean-Stark
2: tri-tert-butyl phosphine; caesium carbonate; palladium diacetate / toluene / 16 h / 110 °C / Inert atmosphere
3: trifluoroacetic acid / dichloromethane / 16 h / 20 °C
View Scheme
(trifluoromethyl)trimethylsilane
81290-20-2

(trifluoromethyl)trimethylsilane

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

1-(6-bromonaphthalen-2-yl)-2,2,2-trifluoroethanol

1-(6-bromonaphthalen-2-yl)-2,2,2-trifluoroethanol

Conditions
ConditionsYield
Stage #1: (trifluoromethyl)trimethylsilane; 6-bromo-naphthalene-2-carboxaldehyde With tetrabutyl ammonium fluoride In tetrahydrofuran at 20℃;
Stage #2: With hydrogenchloride In tetrahydrofuran; water at 20℃; for 1h;
70%
N,N-diphenyl-4-(phenyl(trimethylsilyl)methyl)aniline

N,N-diphenyl-4-(phenyl(trimethylsilyl)methyl)aniline

6-bromo-naphthalene-2-carboxaldehyde
170737-46-9

6-bromo-naphthalene-2-carboxaldehyde

(E)-4-(2-(6-bromonaphthalene-2-yl)-1-phenylvinyl)-N,N-diphenylaniline

(E)-4-(2-(6-bromonaphthalene-2-yl)-1-phenylvinyl)-N,N-diphenylaniline

Conditions
ConditionsYield
Stage #1: N,N-diphenyl-4-(phenyl(trimethylsilyl)methyl)aniline With n-butyllithium In tetrahydrofuran at -78 - 20℃; for 8h;
Stage #2: 6-bromo-naphthalene-2-carboxaldehyde In tetrahydrofuran at 20℃; for 24h;
66%

170737-46-9Relevant articles and documents

METHODS OF DETECTING NEUROLOGICAL DISORDERS VIA BINDING TO PHOSPHORYLATED TAU PROTEIN

-

Page/Page column 88; 89, (2021/04/01)

Provided herein are methods and compositions for determining whether a patient suffers from a neurological disease or disorder is provided, comprising detecting the presence of a phosphorylated tau protein in a tissue of the patient, wherein the detecting comprises contacting the phosphorylated tau protein with a compound described herein.

Exploring the Effect of Aliphatic Substituents on Aryl Cyano Amides on Enhancement of Fluorescence upon Binding to Amyloid-β Aggregates

Ehrlich, Rachel S.,Shiao, Alexander L.,Li, Meihan,Teppang, Kristine L.,Jeoung, Kun Yong,Theodorakis, Emmanuel A.,Yang, Jerry

, p. 2946 - 2952 (2021/08/06)

The self-assembly of amyloid-β (Aβ) peptides into amyloid aggregates is a pathological hallmark of Alzheimer's Disease. We previously reported a fluorescent Aryl Cyano Amide (ARCAM) probe that exhibits an increase in fluorescence emission upon binding to Aβ aggregates in solution and in neuronal tissue. Here, we investigate the effect of introducing small aliphatic substituents on the spectroscopic properties of ARCAM both free in solution and when bound to aggregated Aβ. We found that introducing substituents designed to hinder the rotation of bonds between the electron donor and acceptor on these fluorophores can affect the overall brightness of fluorescence emission of the probes in amyloid-free solutions, but the relative fluorescence enhancement of these probes in amyloid-containing solutions is dependent on the location of the substituents on the ARCAM scaffold. We also observed the capability to tune the excitation or emission wavelength of these probes by introducing electron-donating or -withdrawing substituents that putatively affect either the energy required for photoexcitation or the stability of the photoexcited state. These studies reveal new design principles for developing ARCAM-based fluorescent Aβ-binding probes with an enhanced fluorescence signal compared to background and tunable spectroscopic properties, which may lead to improved chemical tools for aiding in the diagnosis of amyloid-associated neurodegenerative diseases.

COMPOSITIONS AND METHODS FOR DETECTION OF TRAUMATIC BRAIN INJURY

-

, (2021/12/03)

The present disclosure relates generally to compositions and methods for determining whether a patient suffers from a traumatic brain injury (TBI) by detecting the presence of an amyloid beta protein in an eye of the patient. Also provided are compositions and methods for preparing a patient for diagnosis and treatment of traumatic brain injury (TB).

Photoactuators based on the dynamic molecular crystals of naphthalene acrylic acids driven by stereospecific [2+2] cycloaddition reactions

Liu, Jiaxi,Ye, Kaiqi,Shen, Yanbing,Peng, Jiang,Sun, Jingbo,Lu, Ran

, p. 3165 - 3175 (2020/03/19)

The photomechanical effects of the dynamic molecular crystals of halogen-substituted naphthalene acrylic acids (1FNaAA, 1ClNaAA, 1BrNaAA, 1INaAA and 6BrNaAA) have been investigated. Upon UV irradiation, the needle-like crystal of 1FNaAA curls away from the light source, while the slice-like crystal of 6BrNaAA bends towards the light source. Moreover, the light-induced bending, flipping and bursting are observed for the elongated needle-like crystals of 1FNaAA, and the slice-like crystals of 1ClNaAA and 1BrNaAA show bending, cracking, coiling, rotating and twisting triggered by 365 nm light. It is found that stereospecific [2+2] cycloaddition reactions take place in the crystals to afford one stereoisomer of β-type cyclobutanes, since 1FNaAA, 1ClNaAA, 1BrNaAA and 6BrNaAA pack in a head-to-head mode, which satisfies the Schmidt's topo-photochemical criteria. The strain can be generated and accumulated during the photodimerization, and the release of the strain leads to the photomechanical effects. This provides new clues for the development of photomechanical molecular crystals based on acrylic acids bearing halogen-substituted aromatic units.

A dicyanoisophorone-based, near-infrared, lysosome-targeting pH sensor with an extremely large Stokes shift

Cai, Chunhui,Shen, Wei,Wang, Lei,Yi, Wenjun,Yu, Shian,Zhu, Qing,Zhu, Shen

, (2020/02/27)

Intracellular pH plays an important role in various biological processes; abnormal pH changes in the intracellular compartment leads to the production of free radicals, the disruption of membrane contractility, inappropriate apoptosis, and necrosis, resulting in serious illness. Although fluorescent probes have widely been used to detect pH levels owing to their high sensitivity and specificity, there is still a demand for near-infrared (NIR) fluorescent probes with high Stokes shift. Here, a NIR fluorescent probe, PipDC, comprising N-ethyl piperazine (response unit) and naphthyl dicyanoisophorone (fluorophore), was designed for pH sensing. The probe has an extremely large Stokes shift (290 nm), and its fluorescence intensity at 730 nm sharply increases when the environment changes from basic to acidic owing to the protonation of piperazine, which results in the quenching of the photoinduced electron transfer effect. It exhibited a specific response to acidic microenvironments regardless of other interfering substances. In addition, PipDC operates well in the lysosome environment in living cells and displays an off-on fluorescence response with pH alterations. Together, these results suggest that PipDC is a promising fluorescent probe for intracellular pH sensing.

Design, synthesis, and characterization of 6-[(trimethyl)silylethynyl]naphthalene-2-ethene: A new precursor for the preparation of high-refractive-index organic materials

Hannu-Kuure, Milja,K?rkk?inen, Ari,Legrand, Sacha

, (2020/03/19)

A new polymerizable naphthalene derivative has been designed, prepared, and characterized by 1H, 13C NMR, and MS. The new monomer synthesis has successfully been accomplished from a cheap commercially available raw material, in only four steps with good yields. The four steps can be easily scaled up for manufacturing purposes. It is anticipated that the new precursor can be very useful in the preparation of valuable materials with high refractive index for numerous opto-electronic applications.

Method to discriminate amyloids using fluorescent probes

Teppang, Kristine L.,Ehrlich, Rachel S.,Yang, Jerry

, p. 91 - 114 (2020/04/28)

The aggregation of misfolded proteins into amyloids is a common characteristic of many neurodegenerative and non-neurologic diseases. Fluorescent amyloid-targeting probes that discriminate amyloids based on differences in protein composition can provide rapid information to aid in disease diagnosis. In this chapter, we present protocols for the synthesis and use of ANCA-11 as an environmentally-sensitive amyloid-targeting probe that can fluorescently discriminate between amyloids with different disease origin. We also present a protocol for preparing amyloid samples of synthetic Amyloid-β(1-42), as problems with amyloid preparations can be a large driver of time and cost for research. The methods presented here can be generalized for evaluation of other amyloid-targeting fluorescent probes with different aggregates of amyloidogenic proteins in solution or in tissue.

Comprehensive structure-activity-relationship of azaindoles as highly potent FLT3 inhibitors

Grimm, Sebastian H.,Gagestein, Berend,Keijzer, Jordi F.,Liu, Nora,Wijdeven, Ruud H.,Lenselink, Eelke B.,Tuin, Adriaan W.,van den Nieuwendijk, Adrianus M.C.H.,van Westen, Gerard J.P.,van Boeckel, Constant A.A.,Overkleeft, Herman S.,Neefjes, Jacques,van der Stelt, Mario

, p. 692 - 699 (2019/01/22)

Acute myeloid leukemia (AML) is characterized by fast progression and low survival rates, in which Fms-like tyrosine kinase 3 (FLT3) receptor mutations have been identified as a driver mutation in cancer progression in a subgroup of AML patients. Clinical trials have shown emergence of drug resistant mutants, emphasizing the ongoing need for new chemical matter to enable the treatment of this disease. Here, we present the discovery and topological structure-activity relationship (SAR) study of analogs of isoquinolinesulfonamide H-89, a well-known PKA inhibitor, as FLT3 inhibitors. Surprisingly, we found that the SAR was not consistent with the observed binding mode of H-89 in PKA. Matched molecular pair analysis resulted in the identification of highly active sub-nanomolar azaindoles as novel FLT3-inhibitors. Structure based modelling using the FLT3 crystal structure suggested an alternative, flipped binding orientation of the new inhibitors.

Enantioselective α-Benzylation of Acyclic Esters Using π-Extended Electrophiles

Schwarz, Kevin J.,Yang, Chao,Fyfe, James W. B.,Snaddon, Thomas N.

supporting information, p. 12102 - 12105 (2018/09/11)

The first asymmetric cooperative Lewis base/palladium catalyzed benzylic alkylation of acyclic esters is reported. This reaction proceeds via stereodefined C1-ammonium enolate nucleophiles. Critical to its success was the identification of benzylic phosphate electrophiles, which were uniquely reactive. Alkylated products were obtained with very high levels of enantioselectivity, and this method has been applied toward the synthesis of the thrombin inhibitor DX-9065a.

CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE

-

, (2018/07/29)

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 170737-46-9